Eur Rev Med Pharmacol Sci 2023; 27 (21): 10785-10797
DOI: 10.26355/eurrev_202311_34358

Retrospective analysis of respiratory virus infections in adults with hematologic malignancies

K. Şanli, M. Ayer, S. Alaçam, A. Gümüş, N. Karabulut

Department of Medical Microbiology, University of Health Science, Başakşehir Çam and Sakura City Hospital, Istanbul, Turkey. kamuran67@gmail.com


OBJECTIVE: The study aimed to evaluate respiratory virus infections in adult patients with hematological malignancies (HM).

PATIENTS AND METHODS: The medical records of patients who were followed up by the hematology clinic at Başakşehir Çam and Sakura City Hospital between March 2021 and March 2023 with a diagnosis of HM and who underwent real-time polymerase chain reaction (RT-PCR) testing for nasopharyngeal/oropharyngeal specimens taken with suspected respiratory tract infection constituted the study data.

RESULTS: Infections were symptomatic in 64.56% of patients, and the most common symptoms were fever (48.10%) and cough (18.99%). The mortality rate was 25.32% over a two-year period. When the samples were examined, positive test frequency was 43.04%, and the three most common pathogens were Influenza A (10.13%), SARS-CoV-2 (8.86%), and rhinovirus/enterovirus (7.59%). The frequency of positive tests from HMs was highest in patients with AML (p=0.042). Respiratory PCR kit positivity was higher in patients who had any symptoms (p=0.002) and cough (p=0.003). Test positivity was higher in patients with any pathological radiological finding (p=0.039) and ground glass appearance (p=0.010). The risk of death was found to be 5.848 times higher in patients with dyspnea compared to those without (OR: 5.848, 95% CI: 1.143-29.915, p=0.034).

CONCLUSIONS: Respiratory tract virus panel PCR test positivity is more common in patients with HM presenting with respiratory tract infection symptoms in the presence of AML diagnosis, symptomatic infection, cough, radiological findings, and ground glass appearance. Mortality risk is high in HM patients with respiratory tract virus infection who have shortness of breath.

Free PDF Download

To cite this article

K. Şanli, M. Ayer, S. Alaçam, A. Gümüş, N. Karabulut
Retrospective analysis of respiratory virus infections in adults with hematologic malignancies

Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 21
Pages: 10785-10797
DOI: 10.26355/eurrev_202311_34358